Partnerships

Sanofi has entered into a new collaboration with Dr.Carl Nathan's laboratory at Weill Cornell Medical College to screen existing compounds and develop new compounds to shorten the course of treatment...

University of California, San Francisco (UCSF) has entered into a broad collaboration agreement with Sanofi to develop new therapies to treat Diabetes (Type 1 & 2). Scientists with deep...

The DDU is now leading the SDDC. The Structure-guided Drug Discovery Coalition (SDDC) is an international research coalition led by the Structural Genomics Consortium, based at McGill University,...

The mission of Senex Biotechnology is to discover and develop therapeutic agents to effectively treat cancer, viral diseases and age-related diseases, such as Alzheimer's, renal disease,...

Takeda Pharmaceuticals has entered into a collaboration with Florida Hospital and Sanford-Burnham Medical Institute to discover and develop new therapeutic approaches to treat obesity. The two...

• The TB Drug Accelerator Programme aims to speed up the discovery and development of novel compounds against tuberculosis (TB).

A vital asset of the MRC-PPU is the Division of Signal Transduction Therapy (DSTT) which was established in 1998. This division operates as a unique collaboration between scientists in the MRC-PPU...

UCB has entered into a research and development partnership with Oxford University in Neurology and Immunology areas. UCB will provide 3.6 million pounds to Oxford scientists over a period of three...

UCB as agreed to fund and support a third research project called "Mining the Human Microbiome" as part of the UCB-Harvard Research Alliance. UCB will be providing $4.5 million over a period of...

University of California, San Francisco (UCSF) and Genetech have entered into a research collaboration to develop drugs to treat neurodegenerative diseases. Genetech will be providing funding to...